{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:32:00Z","timestamp":1758054720492,"version":"3.44.0"},"reference-count":35,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023950","name":"QIAGEN","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100023950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tuberculosis Foundation of Virginia","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,4]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Despite low sensitivity and implementation challenges, the tuberculin skin test (TST) remains the standard-of-care tuberculosis (TB) infection test in Mexico. Interferon gamma release assays (IGRA) may overcome TST-related challenges. Within the confines of the local programmatic setting, this cross-sectional study evaluated the prevalence of TB infection (TBI) and concordance of TST and IGRA in three high-risk populations in Mexicali, Baja California, Mexico.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Household contacts (HHC) of individuals with TB, people who use drugs (PWUD), people deprived of liberty (PDL) and prison employees underwent evaluation for TBI using TST and QIAreach, a novel IGRA. Prevalence of infection, concordance of test results and reactivity trends of time-to-results (TTR) by TST-induration size were assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 214 of 411 (52.07%) people who had TST and 269 of 460 (58.48%) people who had IGRA tested positive for TBI. Frequency of infection varied across risk groups (HHC 29 (29.6%); PWUD 67 (70.53%); PDL 111 (56.06%) and prison employees 7 (35.0%), p&lt;0.001). Overall concordance of TST and IGRA was 74.4%. Among people without a BCG vaccination, TTR decreased as TST induration size increased (from 1200 s in 0\u20134 mm to 808 s in &gt;20 mm, p=0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>All risk groups had a high frequency of TBI, necessitating locally tailored guidelines for screening, treatment and management of TBI to optimise care for vulnerable populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097505","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:25:33Z","timestamp":1757913933000},"page":"e097505","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing tuberculosis infection prevalence and test concordance in high-risk groups: a cross-sectional study in Mexicali, Baja California"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-7012","authenticated-orcid":false,"given":"Amanda","family":"Brumwell","sequence":"first","affiliation":[{"name":"Advance Access & Delivery, Durham, North Carolina, USA"},{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Herrera","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Durango, Campus Mexicali, Mexicali, Baja California, Mexico"},{"name":"Tuberculosis Program, Mexicali Health Jurisdiction, Mexicali, Baja California, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Contreras","sequence":"additional","affiliation":[{"name":"Tuberculosis Program, Mexicali Health Jurisdiction, Mexicali, Baja California, Mexico"},{"name":"Universidad Aut\u00f3noma de Baja California, Mexicali, Baja California, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildred","family":"Lee","sequence":"additional","affiliation":[{"name":"Tuberculosis Program, Mexicali Health Jurisdiction, Mexicali, Baja California, Mexico"},{"name":"Universidad Aut\u00f3noma de Baja California, Mexicali, Baja California, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Becerra","sequence":"additional","affiliation":[{"name":"Tuberculosis Program, Mexicali Health Jurisdiction, Mexicali, Baja California, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Estrada-Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Tuberculosis Program, Mexicali Health Jurisdiction, Mexicali, Baja California, Mexico"},{"name":"Universidad Aut\u00f3noma de Baja California, Mexicali, Baja California, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Advance Access & Delivery, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"Machado Contreras","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Baja California, Mexicali, Baja California, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1022-2515","authenticated-orcid":false,"given":"Meredith B","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"2025091422251554000_15.9.e097505.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"2025091422251554000_15.9.e097505.2","unstructured":"World Health Organization . Global tuberculosis report. 2023. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/373828\/9789240083851-eng.pdf?sequence=1"},{"key":"2025091422251554000_15.9.e097505.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146098","article-title":"The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda","volume":"11","author":"Biraro","year":"2016","journal-title":"PLoS ONE"},{"key":"2025091422251554000_15.9.e097505.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00323-2"},{"key":"2025091422251554000_15.9.e097505.5","doi-asserted-by":"crossref","unstructured":"Smieja M , Marchetti C , Cook D , et al . Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 1999. doi:10.1002\/14651858.cd001363","DOI":"10.1002\/14651858.CD001363"},{"key":"2025091422251554000_15.9.e097505.6","unstructured":"WHO . WHO Consolidated Guidelines on Tuberculosis Module 2: Screening Systemic Screening for Tuberculosis Disease. 2020."},{"key":"2025091422251554000_15.9.e097505.7","unstructured":"WHO . Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization, 2018."},{"key":"2025091422251554000_15.9.e097505.8","article-title":"Morbidity Trends and Risk of Tuberculosis: Mexico 2007-2017","volume":"2019","author":"Bello-L\u00f3pez","year":"2019","journal-title":"Can Respir J"},{"key":"2025091422251554000_15.9.e097505.9","first-page":"962","article-title":"Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico","volume":"13","author":"Burgos","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025091422251554000_15.9.e097505.10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.5588\/ijtld.21.0391","article-title":"Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis","volume":"25","author":"Stieber","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025091422251554000_15.9.e097505.11","doi-asserted-by":"crossref","first-page":"14455","DOI":"10.1038\/s41598-024-65663-4","article-title":"Evaluating the diagnostic accuracy of QIAreach QuantiFERON-TB compared to QuantiFERON-TB Gold Plus for tuberculosis: a systematic review and meta-analysis","volume":"14","author":"Mahmoudi","year":"2024","journal-title":"Sci Rep"},{"key":"2025091422251554000_15.9.e097505.12","unstructured":"CENAPRECE . Programa de acci\u00f3n espec\u00edfico prevenci\u00f3n y control de la tuberculosis. Programa Sect Salud; 2013. Available: http:\/\/www.cenaprece.salud.gob.mx\/descargas\/pdf\/PAE_PrevencionControlTuberculosis2013_2018.pdf"},{"key":"2025091422251554000_15.9.e097505.13","unstructured":"QIAGEN . QIAreach ehub user manual. 2021.1\u201340."},{"key":"2025091422251554000_15.9.e097505.14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1020-49892012000700005","article-title":"Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico","volume":"32","author":"Velasquez","year":"2012","journal-title":"Rev Panam Salud Publica"},{"key":"2025091422251554000_15.9.e097505.15","doi-asserted-by":"crossref","unstructured":"World Health Organization . WHO consolidated guidelines on tuberculosis. Module 1: Tuberculosis preventive treatment. 2020.","DOI":"10.30978\/TB2021-2-86"},{"key":"2025091422251554000_15.9.e097505.16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/s1806-37562017000000443","article-title":"Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs","volume":"44","author":"Silva","year":"2018","journal-title":"J Bras Pneumol"},{"key":"2025091422251554000_15.9.e097505.17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5588\/ijtld.22.0650","article-title":"Smoked drug use in patients with TB is associated with higher bacterial burden","volume":"27","author":"Myers","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025091422251554000_15.9.e097505.18","doi-asserted-by":"publisher","DOI":"10.1086\/594126"},{"key":"2025091422251554000_15.9.e097505.19","first-page":"626","article-title":"High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico","volume":"13","author":"Garfein","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025091422251554000_15.9.e097505.20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"The Lancet"},{"key":"2025091422251554000_15.9.e097505.21","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.5588\/ijtld.14.0179","article-title":"High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons","volume":"18","author":"Rueda","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025091422251554000_15.9.e097505.22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12879-022-07961-8","article-title":"Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB","volume":"23","author":"Placeres","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025091422251554000_15.9.e097505.23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0764-8"},{"key":"2025091422251554000_15.9.e097505.24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5588\/ijtld.15.0056","article-title":"Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection","volume":"20","author":"Aguilera","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025091422251554000_15.9.e097505.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207400","article-title":"Tuberculosis among correctional facility workers: A systematic review and meta-analysis","volume":"13","author":"Grenzel","year":"2018","journal-title":"PLoS ONE"},{"key":"2025091422251554000_15.9.e097505.26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10900-023-01201-z","article-title":"Latent Tuberculosis Infection Diagnosis Using QuantiFERON-TB Gold Plus Kit Among Correctional Workers: A Cross-Sectional Study in Francisco Beltr\u00e3o-PR, Brazil","volume":"48","author":"Trevisol","year":"2023","journal-title":"J Community Health"},{"key":"2025091422251554000_15.9.e097505.27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/tmi.13808","article-title":"Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary tb patients in high tb burden countries \u2010 a systematic review and meta\u2010analysis","volume":"27","author":"Sagili","year":"2022","journal-title":"Tropical Med Int Health"},{"key":"2025091422251554000_15.9.e097505.28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.arcmed.2013.02.004","article-title":"Performance of tuberculin skin test compared to QFT-IT to detect latent TB among high-risk contacts in Mexico","volume":"44","author":"Serrano-Escobedo","year":"2013","journal-title":"Arch Med Res"},{"key":"2025091422251554000_15.9.e097505.29","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.tube.2011.10.007","article-title":"Snapshot of Quantiferon TB gold testing in Northern Mexico","volume":"91 Suppl 1","author":"Gonz\u00e1lez-Salazar","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"2025091422251554000_15.9.e097505.30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpubh.2015.00220","article-title":"Interferon Gamma-Based Detection of Latent Tuberculosis Infection in the Border States of Nuevo Leon and Tamaulipas, Mexico","volume":"3","author":"Oren","year":"2015","journal-title":"Front Public Health"},{"key":"2025091422251554000_15.9.e097505.31","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.9.804"},{"key":"2025091422251554000_15.9.e097505.32","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2019.01.048","article-title":"Tuberculin skin test - Outdated or still useful for Latent TB infection screening?","volume":"80S","author":"Gualano","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2025091422251554000_15.9.e097505.33","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2301-4"},{"key":"2025091422251554000_15.9.e097505.34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"2025091422251554000_15.9.e097505.35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1590\/0074-0276140085","article-title":"Serial QuantiFERON-TB Gold In-Tube assay and tuberculin skin test to diagnose latent tuberculosis in household Mexican contacts: conversion and reversion rates and associated factors using conventional and borderline zone definitions","volume":"109","author":"Mon\u00e1rrez-Espino","year":"2014","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:25:38Z","timestamp":1757913938000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,14]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2024-097505"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097505","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}